NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $10.6K, a 71% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $10.6K -$25.9K -71% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.6K -$47.7K -70.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $11.3K -$86.6K -88.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $20.3K -$108K -84.2% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $36.5K -$122K -77% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $67.3K -$122K -64.4% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $97.9K -$122K -55.5% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $128K -$122K -48.7% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $159K -$122K -43.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $189K -$121K -39% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $220K -$120K -35.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $250K -$31.6K -11.2% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $280K -$25.8K -8.43% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $310K -$26.6K -7.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $340K -$27.4K -7.45% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $282K -$125K -30.8% Dec 31, 2019 10-K 2021-03-26
Q3 2019 $306K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $337K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $367K Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $407K Jan 1, 2019 10-K 2021-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.